← Back to Search

Hormone Therapy

Healthy Young Women for E-Cigarette Use

Phase < 1
Recruiting
Research Sponsored by Anna Stanhewicz, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Either have no history of e-cigarette use or be a current e-cigarette user who has been using e-cigarettes for 6 months or longer
Aged 18-24 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will explore the effects of e-cigarette use on mechanisms which could lead to CVD in young adults.

Who is the study for?
This trial is for healthy young adults aged 18-24 who either have never used e-cigarettes or have been vaping regularly for at least 6 months. Participants should not have any cardiovascular, metabolic, skin diseases, obesity, high blood pressure, a history of smoking tobacco cigarettes or using illegal substances. Pregnant or breastfeeding individuals and those with allergies to latex or study drugs are also excluded.Check my eligibility
What is being tested?
The study investigates how chronic e-cigarette use affects the blood vessels in young adults by comparing non-users to regular users. It involves local heating of the skin and administering L-NAME via microdialysis to test vascular function. Blood and urine samples will be collected from participants to analyze cardiovascular health markers and inflammation.See study design
What are the potential side effects?
Potential side effects may include reactions at the site where drugs are administered into the skin (like redness or swelling), changes in blood pressure due to L-NAME which inhibits nitric oxide production affecting vessel dilation, and discomfort from heat application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I either have never used e-cigarettes or have been using them for over 6 months.
Select...
I am between 18 and 24 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in microvascular endothelium-dependent dilation response measured by laser-Doppler flowmetry
monthly estrogen exposure

Trial Design

4Treatment groups
Experimental Treatment
Group I: Young Women using E-cigarettesExperimental Treatment2 Interventions
Young women chronically use e-cigarettes
Group II: Young Men using E-cigarettesExperimental Treatment1 Intervention
Young men chronically use e-cigarettes
Group III: Healthy Young WomenExperimental Treatment2 Interventions
Young women who do not use e-cigarettes
Group IV: Healthy Young MenExperimental Treatment1 Intervention
Young men who do not use e-cigarettes

Find a Location

Who is running the clinical trial?

Anna Stanhewicz, PhDLead Sponsor
9 Previous Clinical Trials
300 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals of any age eligible for this research trial?

"Participants who meet the age requirements of 18 years and below 24 can be enrolled in this clinical trial."

Answered by AI

What criteria must be met in order to join this experiment?

"This research initiative requires that enrollees are between 18 and 24 years of age, have a history of e-cigarette use, and is looking to recruit approximately 80 people."

Answered by AI

What is the current recruitment count for this experiment?

"Affirmative. The information on clinicaltrials.gov confirms that this research is currently enrolling participants, which it first did in November of 2024 and was most recently updated in December 2023. 80 candidates must be sourced from one medical site for the study to commence."

Answered by AI

Are there any vacancies available for individuals to join this clinical trial?

"Affirmative. According to information provided on clinicaltrials.gov, this experiment is actively seeking participants. Initially posted in November 1st 2024 and recently updated in December 4th 2023, the study needs to enrol 80 individuals from one medical centre."

Answered by AI
~53 spots leftby Nov 2025